T1	intervention 62 72	vitamin D3
T2	condition 91 129	aromatase inhibitor-induced arthralgia
T3	eligibility 473 533	post-menopausal women who were beginning adjuvant AI therapy
T4	duration 645 654	12Â weeks,
T5	control 545 569	standard-dose vitamin D3
T6	outcome-Measure 722 740	development of AIA
T7	No-of-participants 775 778	184
T8	No-of-participants 832 834	93
T11	outcome 1064 1077	developed AIA
T12	intervention-value 1046 1048	25
T13	intervention-value 1059 1062	54%
T14	control-value 1091 1093	27
T15	control-value 1104 1107	57%
T9	outcome 916 938	serum vitamin D levels
